SalveoDx is a stealth diagnostics startup focused on single-drop-of-blood testing, per its website and the article. The company is described as a San Diego-based spinout of Domain Associates and is keeping technical details confidential while in stealth. Its rudimentary site uses marketing phrases such as "your life in a drop of blood" and "changing life and labs forever," but offers no product specifics. The article reports SalveoDx has raised $2 million in equity; no revenue, user, valuation, or other operating metrics were disclosed. Directors named in the coverage include Pieter van Rooyen—also CEO of Edico Genome—and Bala Manian; the article notes that applying Edico Genome’s rapid-sequencing expertise to single-drop diagnostics could be powerful. Given recent scrutiny of companies in this segment (the article references Theranos), the company appears to be deliberately remaining quiet while it develops its offering.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2015